Recent Company News

• 09:26 AM ET Dec 31, 2025
  

  Global drugmakers raise list prices for 2026 - Reuters

• 08:37 AM ET Dec 29, 2025
  

  Ultragenyx Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta did not meet primary endpoint ($34.19, 0.00)

• 10:02 AM ET Dec 23, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (170 total)

• 08:40 AM ET Dec 23, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 10:44 AM ET Dec 22, 2025
  

  StreetAccount Summary - Private company transactions for the week ended 20-Dec

• 10:03 PM ET Dec 20, 2025
  

  Roche CEO: Drug deals with Trump administration mean prices will rise in Switzerland - Tages-Anzeiger (CHF 325.50, 0.00)

• 04:58 PM ET Dec 19, 2025
  

  CMS announces GLOBE and GUARD pricing models for Medicare Part B and Part D

• 03:25 PM ET Dec 19, 2025
  

  StreetAccount Summary - Politics of the Market preview: week of 22-Dec

• 02:43 PM ET Dec 19, 2025
  

  White House MFN event underway

• 02:31 PM ET Dec 19, 2025
  

  Novartis and US government reach agreement on lowering drug prices in the US (CHF 108.52, 0.00)